The DOI matches its Crossref record; 213 of the 213 references it cites were found in a registry or an index.
Nanopreparations for organelle-specific delivery in cancer
Open accessAbstract
To efficiently deliver therapeutics into cancer cells, a number of strategies have been recently investigated. The toxicity associated with the administration of chemotherapeutic drugs due to their random interactions throughout the body necessitates the development of drug-encapsulating nanopreparations that significantly mask, or reduce, the toxic side effects of the drugs. In addition to reduced side effects associated with drug encapsulation, nanocarriers preferentially accumulate in tumors as a result of its abnormally leaky vasculature via the Enhanced Permeability and Retention (EPR) effect. However, simple passive nanocarrier delivery to the tumor site is unlikely to be enough to elicit a maximum therapeutic response as the drug-loaded carriers must reach the intracellular target sites. Therefore, efficient translocation of the nanocarrier through the cell membrane is necessary for cytosolic delivery of the cargo. However, Crossing the cell membrane barrier and reaching cytosol might still not be enough for achieving maximum therapeutic benefit, which necessitates the delivery of drugs directly to intracellular targets, such as bringing pro-apoptotic drugs to mitochondria, nucleic acid therapeutics to nuclei, and lysosomal enzymes to defective lysosomes. In this review, we discuss the strategies developed for tumor targeting, cytosolic delivery via cell membrane translocation, and finally organelle-specific targeting, which may be applied for developing highly efficacious, truly multifunctional, cancer-targeted nanopreparations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Fang, J., Nakamura, H., & Maeda, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.009 · Cited by 3,559
Impact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,348
Therapeutic Nanoparticles for Drug Delivery in Cancer
Cho, K., Wang, X., Nie, S., Chen, Z. (., & Shin, D. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1441 · Cited by 2,920
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
Cellular uptake of the tat protein from human immunodeficiency virus
Frankel, A. D., & Pabo, C. O. (1988) · Cell · doi:10.1016/0092-8674(88)90263-2 · Cited by 2,783
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Vivès, E., Brodin, P., & Lebleu, B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.25.16010 · Cited by 2,373
The third helix of the Antennapedia homeodomain translocates through biological membranes.
Derossi, D., Joliot, A. H., Chassaing, G., & Prochiantz, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34080-2 · Cited by 2,034
Tumor delivery of macromolecular drugs based on the EPR effect
Torchilin, V. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.011 · Cited by 2,032
Self-citation(2016) · CRC Press eBooks · doi:10.1201/b12801 · Cited by 2,031
Humanization of an anti-p185HER2 antibody for human cancer therapy.
Carter, P., Presta, L., Gorman, C. M., Ridgway, J. B., Henner, D., Wong, W. L., Rowland, A. M., Kotts, C., Carver, M. E., & Shepard, H. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4285 · Cited by 1,918
Exploiting the enhanced permeability and retention effect for tumor targeting
Iyer, A. K., Khaled, G., Fang, J., & Maeda, H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.005 · Cited by 1,846
VEGF as a Key Mediator of Angiogenesis in Cancer
Carmeliet, P. (2005) · Oncology · doi:10.1159/000088478 · Cited by 1,768
Active targeting schemes for nanoparticle systems in cancer therapeutics
Byrne, J. D., Betancourt, T., & Brannon-Peppas, L. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.005 · Cited by 1,731
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., & Langer, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601755103 · Cited by 1,663
General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia.
Wang, G. L., & Semenza, G. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.4304 · Cited by 1,468
Richard, J. P., Melikov, K., Vives, E., Ramos, C., Verbeure, B., Gait, M. J., Chernomordik, L. V., & Lebleu, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209548200 · Cited by 1,446
Lysosomal membrane permeabilization in cell death
Boya, P., & Kroemer, G. (2008) · Oncogene · doi:10.1038/onc.2008.310 · Cited by 1,426
Baselga, J., Tripathy, D., Mendelsohn, J., Baughman, S., Benz, C. C., Dantis, L., Sklarin, N. T., Seidman, A. D., Hudis, C. A., Moore, J., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.3.737 · Cited by 1,380
Lysosomes and autophagy in cell death control
Kroemer, G., & Jäättelä, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1738 · Cited by 1,285
TORCHILIN, V (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.009 · Cited by 1,273
Self-citationTat-mediated delivery of heterologous proteins into cells.
Fawell, S., Seery, J., Daikh, Y., Moore, C., Chen, L. L., Pepinsky, B., & Barsoum, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.664 · Cited by 1,225
Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect
Maeda, H., Bharate, G. Y., & Daruwalla, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.11.010 · Cited by 1,168
Fleige, E., Quadir, M. A., & Haag, R. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.01.020 · Cited by 1,111
Selective Targeting of a Redox-active Ubiquinone to Mitochondria within Cells
Kelso, G. F., Porteous, C. M., Coulter, C. V., Hughes, G., Porteous, W. K., Ledgerwood, E. C., Smith, R. A. J., & Murphy, M. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009093200 · Cited by 1,091
Mitochondrial Membrane Potential in Living Cells
Chen, L. B. (1988) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.04.110188.001103 · Cited by 1,037
Chen, J., Wang, D., Xi, J., Au, L., Siekkinen, A., Warsen, A., Li, Z.-Y., Zhang, H., Xia, Y., & Li, X. (2007) · Nano Letters · doi:10.1021/nl070345g · Cited by 1,025
Nucleocytoplasmic transport: signals, mechanisms and regulation
Nigg, E. A. (1997) · Nature · doi:10.1038/386779a0 · Cited by 996
Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.
Pasqualini, R., Koivunen, E., Kain, R., Lahdenranta, J., Sakamoto, M., Stryhn, A., Ashmun, R., Shapiro, L., Arap, W., & Ruoslahti, E. I. (2000) · PubMed · Cited by 966
Nanotechnology: Intelligent Design to Treat Complex Disease
Couvreur, P., & Vauthier, C. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0284-8 · Cited by 948
Nagahara, H., Vocero-Akbani, A. M., Snyder, E. L., Ho, A., Latham, D. G., Lissy, N. A., Becker-Hapak, M., Ezhevsky, S. A., & Dowdy, S. F. (1998) · Nature Medicine · doi:10.1038/4042 · Cited by 928
Cell Death Independent of Caspases: A Review
Bröker, L. E., Kruyt, F. A. E., & Giaccone, G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2223 · Cited by 898
High-Efficiency Intracellular Magnetic Labeling with Novel Superparamagnetic-Tat Peptide Conjugates
Josephson, L., Tung, C.-H., Moore, A., & Weissleder, R. (1999) · Bioconjugate Chemistry · doi:10.1021/bc980125h · Cited by 882
Regulation of angiogenesis via vascular endothelial growth factor receptors.
Veikkola, T., Karkkainen, M. J., Claesson, L., & Alitalo, K. K. (2000) · PubMed · Cited by 864
Tumor Regression by Targeted Gene Delivery to the Neovasculature
Hood, J. D., Bednarski, M., Frausto, R., Guccione, S., Reisfeld, R. A., Xiang, R., & Cheresh, D. A. (2002) · Science · doi:10.1126/science.1070200 · Cited by 858
Lindgren, M., Hällbrink, M., Prochiantz, A., & Langel, Ü. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01447-4 · Cited by 803
The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer
Farhood, H., Serbina, N., & Huang, L. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)80016-9 · Cited by 798
Zhao, K., Zhao, G.-M., Wu, D., Soong, Y., Birk, A. V., Schiller, P. W., & Szeto, H. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402999200 · Cited by 782
Torchilin, V. P., Rammohan, R., Weissig, V., & Levchenko, T. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151247498 · Cited by 777
Self-citationAnti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
Park, J. W., Hong, K., Kirpotin, D. B., Colbern, G. T., Shalaby, R., Baselga, J. M., Shao, Y. Y., Nielsen, U. B., Marks, J. D., Moore, D. H., et al. (2002) · Clinical Cancer Research · Cited by 766
Delivery of bioactive molecules to mitochondria in vivo
Smith, R. A. J., Porteous, C. M., Gane, A. M., & Murphy, M. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931245100 · Cited by 725
Guicciardi, M. E., Leist, M., & Gores, G. J. (2004) · Oncogene · doi:10.1038/sj.onc.1207512 · Cited by 713
Lysosomal storage disorders: The cellular impact of lysosomal dysfunction
Platt, F. M., Boland, B., & van der Spoel, A. C. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201208152 · Cited by 689
Cell penetration by transportan
Pooga, M., Hällbrink, M., Zorko, M., & Langel, U. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.1.67 · Cited by 679
SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy
Maeda, H. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00134-4 · Cited by 662
Mitochondria in cancer cells: what is so special about them?
Gogvadze, V., Orrenius, S., & Zhivotovsky, B. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.01.006 · Cited by 637
You, J., Zhang, G., & Li, C. (2010) · ACS Nano · doi:10.1021/nn901181c · Cited by 597
Cook-Mills, J. M., Marchese, M. E., & Abdala-Valencia, H. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3522 · Cited by 594
Hu-Lieskovan, S., Heidel, J. D., Bartlett, D. W., Davis, M. E., & Triche, T. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0565 · Cited by 567
Design of Folic Acid‐Conjugated Nanoparticles for Drug Targeting
Stella, B., Arpicco, S., Peracchia, M. T., Desmaële, D., Hoebeke, J., Renoir, M., D'Angelo, J., Cattel, L., & Couvreur, P. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200011)89:11<1452::aid-jps8>3.0.co;2-p · Cited by 553
Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles
Rapoport, N. Y., Kennedy, A. M., Shea, J. E., Scaife, C. L., & Nam, K.-H. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.05.026 · Cited by 551
Heat Shock Protein 70 Promotes Cell Survival by Inhibiting Lysosomal Membrane Permeabilization
Nylandsted, J., Gyrd-Hansen, M., Danielewicz, A., Fehrenbacher, N., Lademann, U., Høyer-Hansen, M., Weber, E., Multhoff, G., Rohde, M., & Jäättelä, M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040531 · Cited by 545
RECENT APPROACHES TO INTRACELLULAR DELIVERY OF DRUGS AND DNA AND ORGANELLE TARGETING
Torchilin, V. P. (2006) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.8.061505.095735 · Cited by 543
Self-citationTumour-targeted nanomedicines: principles and practice
Lammers, T., Hennink, W. E., & Storm, G. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604483 · Cited by 542
“SMART” Drug Delivery Systems: Double-Targeted pH-Responsive Pharmaceutical Nanocarriers
Sawant, R. M., Hurley, J. P., Salmaso, S., Kale, A., Tolcheva, E., Levchenko, T. S., & Torchilin, V. P. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060080h · Cited by 540
Self-citationA new peptide vector for efficient delivery of oligonucleotides into mammalian cells
Morris, M. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.14.2730 · Cited by 535
The transferrin receptor part II: Targeted delivery of therapeutic agents into cancer cells
Daniels, T. R., Delgado, T., Helguera, G., & Penichet, M. L. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.06.006 · Cited by 518
Ross, M. F., Kelso, G. F., Blaikie, F. H., James, A. M., Cochemé, H. M., Filipovska, A., Da Ros, T., Hurd, T. R., Smith, R. A. J., & Murphy, M. P. (2005) · Biochemistry (Moscow) · doi:10.1007/s10541-005-0104-5 · Cited by 493
Photochemical mechanisms of light-triggered release from nanocarriers
Fomina, N., Sankaranarayanan, J., & Almutairi, A. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.02.006 · Cited by 491
Selective targeting of an antioxidant to mitochondria
Smith, R. A. J., Porteous, C. M., Coulter, C. V., & Murphy, M. P. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00543.x · Cited by 466
Regulation of apoptosis-associated lysosomal membrane permeabilization
Johansson, A.-C., Appelqvist, H., Nilsson, C., Kågedal, K., Roberg, K., & Öllinger, K. (2010) · Apoptosis · doi:10.1007/s10495-009-0452-5 · Cited by 463
Bidère, N., Lorenzo, H. K., Carmona, S., Laforge, M., Harper, F., Dumont, C., & Senik, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301911200 · Cited by 435
Possible Existence of Common Internalization Mechanisms among Arginine-rich Peptides
Suzuki, T., Futaki, S., Niwa, M., Tanaka, S., Ueda, K., & Sugiura, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110017200 · Cited by 430
Drug delivery to mitochondria: the key to mitochondrial medicine
Murphy, M. P., & Smith, R. A. J. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00069-1 · Cited by 426
Rapoport, N., Nam, K.-H., Gupta, R., Gao, Z., Mohan, P., Payne, A., Todd, N., Liu, X., Kim, T., Shea, J., et al. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.01.022 · Cited by 423
Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome–DNA complexes
Torchilin, V. P., Levchenko, T. S., Rammohan, R., Volodina, N., Papahadjopoulos-Sternberg, B., & D'Souza, G. G. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0435906100 · Cited by 419
Self-citationMultifaceted Activities of the HIV-1 Transactivator of Transcription, Tat
Jeang, K.-T., Xiao, H., & Rich, E. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.28837 · Cited by 414
Droga-Mazovec, G., Bojič, L., Petelin, A., Ivanova, S., Romih, R., Repnik, U., Salvesen, G. S., Stoka, V., Turk, V., & Turk, B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802513200 · Cited by 399
(2002) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(01)00044-9 · Cited by 397
Lysosomal involvement in cell death and cancer
Kirkegaard, T., & Jäättelä, M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.09.008 · Cited by 395
Nylandsted, J., Rohde, M., Brand, K., Bastholm, L., Elling, F., & Jäättelä, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.7871 · Cited by 393
Khalil, I. A., Kogure, K., Futaki, S., & Harashima, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m503202200 · Cited by 390
Lanford, R. E., Kanda, P., & Kennedy, R. C. (1986) · Cell · doi:10.1016/0092-8674(86)90883-4 · Cited by 383
Mamot, C., Drummond, D. C., Noble, C. O., Kallab, V., Guo, Z., Hong, K., Kirpotin, D. B., & Park, J. W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1093 · Cited by 382
Lipids as Targeting Signals: Lipid Rafts and Intracellular Trafficking
Helms, J. B., & Zurzolo, C. (2004) · Traffic · doi:10.1111/j.1600-0854.2004.0181.x · Cited by 376
Selective targeting of bioactive compounds to mitochondria
Murphy, M. P. (1997) · Trends in Biotechnology · doi:10.1016/s0167-7799(97)01068-8 · Cited by 366
Transfected Aequorin in the Measurement of Cytosolic Ca2+ Concentration ([Ca2+]c)
Brini, M., Marsault, R., Bastianutto, C., Alvarez, J., Pozzan, T., & Rizzuto, R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.17.9896 · Cited by 365
Nanoparticle Technologies for Cancer Therapy
Alexis, F., Pridgen, E. M., Langer, R., & Farokhzad, O. C. (2010) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-00477-3_2 · Cited by 364
Jauslin, M. L., Meier, T., Smith, R. A. J., & Murphy, P. M. (2003) · The FASEB Journal · doi:10.1096/fj.03-0240fje · Cited by 358
Role of aminopeptidase N (CD13) in tumor‐cell invasion and extracellular matrix degradation
Saiki, I., Yoneda, J., Azuma, I., Fujii, H., Abe, F., Nakajima, M., & Tsuruo, T. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540122 · Cited by 341
Sahoo, S. K., & Labhasetwar, V. (2005) · Molecular Pharmaceutics · doi:10.1021/mp050032z · Cited by 340
Tumor targeting using anti-her2 immunoliposomes
Park, J. W., Kirpotin, D. B., Hong, K., Shalaby, R., Shao, Y., Nielsen, U. B., Marks, J. D., Papahadjopoulos, D., & Benz, C. C. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00315-7 · Cited by 335
Mitochondria-targeted peptide antioxidants: Novel neuroprotective agents
Szeto, H. H. (2006) · The AAPS Journal · doi:10.1208/aapsj080362 · Cited by 332
A DNA aptamer which binds to and inhibits thrombin exhibits a new structural motif for DNA
Wang, K. Y., McCurdy, S., Shea, R. G., Swaminathan, S., & Bolton, P. H. (1993) · Biochemistry · doi:10.1021/bi00059a003 · Cited by 332
Sahoo, S. K., Ma, W., & Labhasetwar, V. (2004) · International Journal of Cancer · doi:10.1002/ijc.20405 · Cited by 327
Yamada, Y., Akita, H., Kamiya, H., Kogure, K., Yamamoto, T., Shinohara, Y., Yamashita, K., Kobayashi, H., Kikuchi, H., & Harashima, H. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.11.002 · Cited by 321
Huang, G., Chen, H., Dong, Y., Luo, X., Yu, H., Moore, Z., Bey, E. A., Boothman, D. A., & Gao, J. (2013) · Theranostics · doi:10.7150/thno.5411 · Cited by 318
Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery
MAE, M., & LANGEL, U. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.04.004 · Cited by 317
Cell-permeable, mitochondrial-targeted, peptide antioxidants
Szeto, H. H. (2006) · The AAPS Journal · doi:10.1007/bf02854898 · Cited by 316
Cargo delivery kinetics of cell-penetrating peptides
Hällbrink, M., Florén, A., Elmquist, A., Pooga, M., Bartfai, T., & Langel, Ü. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00398-4 · Cited by 312
Mitochondrial gateways to cancer
Galluzzi, L., Morselli, E., Kepp, O., Vitale, I., Rigoni, A., Vacchelli, E., Michaud, M., Zischka, H., Castedo, M., & Kroemer, G. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.08.002 · Cited by 300
Mitochondrial dysfunction in cancer
Modica-Napolitano, J. S., & Singh, K. K. (2004) · Mitochondrion · doi:10.1016/j.mito.2004.07.027 · Cited by 299
Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy.
Pastorino, F., Brignole, C., Marimpietri, D., Cilli, M., Gambini, C., Ribatti, D., Longhi, R., Allen, T. M., Corti, A., & Ponzoni, M. (2003) · PubMed · Cited by 296
VE-Cadherin-Derived Cell-Penetrating Peptide, pVEC, with Carrier Functions
Elmquist, A., Lindgren, M., Bartfai, T., & Langel, Ü. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5316 · Cited by 290
Lysosomes and oxidative stress in aging and apoptosis
Kurz, T., Terman, A., Gustafsson, B., & Brunk, U. T. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.01.009 · Cited by 287
Costantini, P., Belzacq, A.-S., Vieira, H. L., Larochette, N., de Pablo, M. A., Zamzami, N., Susin, S. A., Brenner, C., & Kroemer, G. (2000) · Oncogene · doi:10.1038/sj.onc.1203299 · Cited by 284
Multiple cell death pathways as regulators of tumour initiation and progression
Jäättelä, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207513 · Cited by 283
Biswas, S., Dodwadkar, N. S., Deshpande, P. P., & Torchilin, V. P. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.009 · Cited by 279
Self-citationMatrix Metalloproteinases as Therapeutic Targets in Cancer
Vihinen, P., Ala-aho, R., & Kahari, V.-M. (2005) · Current Cancer Drug Targets · doi:10.2174/1568009053765799 · Cited by 277
Lysosomes as “Suicide Bags” in Cell Death: Myth or Reality?
Turk, B., & Turk, V. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.023820 · Cited by 270
Nanotechnology and aptamers: applications in drug delivery
Levy-Nissenbaum, E., Radovic-Moreno, A. F., Wang, A. Z., Langer, R., & Farokhzad, O. C. (2008) · Trends in Biotechnology · doi:10.1016/j.tibtech.2008.04.006 · Cited by 270
Kakudo, T., Chaki, S., Futaki, S., Nakase, I., Akaji, K., Kawakami, T., Maruyama, K., Kamiya, H., & Harashima, H. (2004) · Biochemistry · doi:10.1021/bi035802w · Cited by 269
Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis
Jiang, A., Lehti, K., Wang, X., Weiss, S. J., Keski-Oja, J., & Pei, D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241293698 · Cited by 267
Roles of lipid polymorphism in intracellular delivery
Hafez, I. M., & Cullis, P. R. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00103-x · Cited by 266
Fretz, M. M., Penning, N. A., Al-Taei, S., Futaki, S., Takeuchi, T., Nakase, I., Storm, G., & Jones, A. T. (2007) · Biochemical Journal · doi:10.1042/bj20061808 · Cited by 257
Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer
Bolhassani, A. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.07.006 · Cited by 257
Dubikovskaya, E. A., Thorne, S. H., Pillow, T. H., Contag, C. H., & Wender, P. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805374105 · Cited by 249
Kim, S. H., Jeong, J. H., Chun, K. W., & Park, T. G. (2005) · Langmuir · doi:10.1021/la0502084 · Cited by 242
Mitochondrial Medicine: Pharmacological targeting of mitochondria in disease
Armstrong, J. S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707288 · Cited by 234
Boddapati, S. V., D’Souza, G. G. M., Erdogan, S., Torchilin, V. P., & Weissig, V. (2008) · Nano Letters · doi:10.1021/nl801908y · Cited by 234
Self-citationLysosomal destabilization in p53-induced apoptosis
Yuan, X.-M., Li, W., Dalen, H., Lotem, J., Kama, R., Sachs, L., & Brunk, U. T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092135599 · Cited by 226
Surface Cathepsin B Protects Cytotoxic Lymphocytes from Self-destruction after Degranulation
Balaji, K. N., Schaschke, N., Machleidt, W., Catalfamo, M., & Henkart, P. A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011836 · Cited by 224
Lysosomal pathways to cell death and their therapeutic applications
Hafner Česen, M., Pegan, K., Špes, A., & Turk, B. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.03.005 · Cited by 222
Kogure, K., Moriguchi, R., Sasaki, K., Ueno, M., Futaki, S., & Harashima, H. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.04.024 · Cited by 218
Bröker, L. E., Huisman, C., Span, S. W., Rodriguez, J. A., Kruyt, F. A. E., & Giaccone, G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3060 · Cited by 206
Saretzki, G., Murphy, M. P., & Von Zglinicki, T. (2003) · Aging Cell · doi:10.1046/j.1474-9728.2003.00040.x · Cited by 203
DQAsome-mediated delivery of plasmid DNA toward mitochondria in living cells
D’Souza, G. G. M., Rammohan, R., Cheng, S.-M., Torchilin, V. P., & Weissig, V. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00297-9 · Cited by 203
Self-citationFolate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA–PEG–folate conjugate
Esmaeili, F., Ghahremani, M. H., Ostad, S. N., Atyabi, F., Seyedabadi, M., Malekshahi, M. R., Amini, M., & Dinarvand, R. (2008) · Journal of Drug Targeting · doi:10.1080/10611860802088630 · Cited by 203
DNA-protein conjugates can enter mitochondria via the protein import pathway
Vestweber, D., & Schatz, G. (1989) · Nature · doi:10.1038/338170a0 · Cited by 199
DQAsomes: A Novel Potential Drug and Gene Delivery System Made from Dequalinium™
Weissig, V., Lasch, J., Erdos, G., Meyer, H. W., Rowe, T. C., & Hughes, J. (1998) · Pharmaceutical Research · doi:10.1023/a:1011991307631 · Cited by 193
A Ligand-Activated Nuclear Localization Signal in Cellular Retinoic Acid Binding Protein-II
Sessler, R. J., & Noy, N. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.026 · Cited by 192
Brunk, U. T., & Svensson, I. (1999) · Redox Report · doi:10.1179/135100099101534675 · Cited by 182
Liposome-Anchored Vascular Endothelial Growth Factor Aptamers
Willis, M. C., Collins, B., Zhang, T., Green, L. S., Sebesta, D. P., Bell, C., Kellogg, E., Gill, S. C., Magallanez, A., Knauer, S., et al. (1998) · Bioconjugate Chemistry · doi:10.1021/bc980002x · Cited by 181
Roles of membrane‐type matrix metalloproteinase‐1 in tumor invasion and metastasis
Sato, H., Takino, T., & Miyamori, H. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00039.x · Cited by 180
Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature
Backer, M. V., Gaynutdinov, T. I., Patel, V., Bandyopadhyaya, A. K., Thirumamagal, B. T. S., Tjarks, W., Barth, R. F., Claffey, K., & Backer, J. M. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0161 · Cited by 180
Octaarginine-modified multifunctional envelope-type nanoparticles for gene delivery
Khalil, I. A., Kogure, K., Futaki, S., Hama, S., Akita, H., Ueno, M., Kishida, H., Kudoh, M., Mishina, Y., Kataoka, K., et al. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302910 · Cited by 178
Drug Targeting Strategies in Cancer Treatment: An Overview
L. Arias, J. (2011) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955711793564024 · Cited by 176
Cho, S., Szeto, H. H., Kim, E., Kim, H., Tolhurst, A. T., & Pinto, J. T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609388200 · Cited by 173
The EPR Effect and Polymeric Drugs: A Paradigm Shift for Cancer Chemotherapy in the 21st Century
Maeda, H., Greish, K., & Fang, J. (2005) · Advances in Polymer Science · doi:10.1007/12_026 · Cited by 173
Surface conjugation of triphenylphosphonium to target poly(amidoamine) dendrimers to mitochondria
Biswas, S., Dodwadkar, N. S., Piroyan, A., & Torchilin, V. P. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.032 · Cited by 170
Self-citationMitoQ--a mitochondria-targeted antioxidant.
Tauskela, J. S. (2007) · PubMed · Cited by 169
Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes
Hatakeyama, H., Akita, H., Ishida, E., Hashimoto, K., Kobayashi, H., Aoki, T., Yasuda, J., Obata, K., Kikuchi, H., Ishida, T., et al. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.04.037 · Cited by 165
NLS bioconjugates for targeting therapeutic genes to the nucleus
Escriou, V., Carrière, M., Scherman, D., & Wils, P. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00184-9 · Cited by 164
Li, L., Wartchow, C. A., Danthi, S. N., Shen, Z., Dechene, N., Pease, J., Choi, H. S., Doede, T., Chu, P., Ning, S., et al. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.10.057 · Cited by 161
Genetic engineering of proteins with cell membrane permeability
Rojas, M., Donahue, J. P., Tan, Z., & Lin, Y.-Z. (1998) · Nature Biotechnology · doi:10.1038/nbt0498-370 · Cited by 159
VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo
Gosk, S., Moos, T., Gottstein, C., & Bendas, G. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.12.021 · Cited by 158
Transfection of mitochondria: strategy towards a gene therapy of mitochondrial DNA diseases
Seibel, P., Trappe, J., Villani, G., Klopstock, T., Papa, S., & Reichmann, H. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.1.10 · Cited by 157
MitoQ administration prevents endotoxin-induced cardiac dysfunction
Supinski, G. S., Murphy, M. P., & Callahan, L. A. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90902.2008 · Cited by 154
Flierl, A., Jackson, C., Cottrell, B. A., Murdock, D. G., Seibel, P., & Wallace, D. C. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00037-6 · Cited by 151
Taratula, O., Garbuzenko, O. B., Savla, R., et al. (2010) · Current Drug Delivery · doi:10.2174/156720111793663642 · Cited by 151
Liposome-Anchored Vascular Endothelial Growth Factor Aptamers
Willis, M. C., Collins, B. T., Zhang, T., Green, L. S., Sebesta, D. P., Bell, C. J., Kellogg, E. A., Gill, S. C., Magallanez, A., Knauer, S., et al. (1998) · Bioconjugate Chemistry · doi:10.1021/bc980200o · Cited by 146
Akita, H., Kudo, A., Minoura, A., Yamaguti, M., Khalil, I. A., Moriguchi, R., Masuda, T., Danev, R., Nagayama, K., Kogure, K., et al. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.02.009 · Cited by 144
Lysosomal cysteine cathepsins: signaling pathways in apoptosis
Stoka, V., Türk, V., & Turk, B. (2007) · Biological Chemistry · doi:10.1515/bc.2007.064 · Cited by 141
MT1-MMP: Universal or particular player in angiogenesis?
Genı́s, L., Gálvez, B. G., Gonzalo, P., & Arroyo, A. G. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-7891-z · Cited by 141
Marcucci, G., Stock, W., Dai, G., Klisovic, R. B., Liu, S., Klisovic, M. I., Blum, W. G., Kefauver, C. A., Sher, D. A., Green, M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.118 · Cited by 141
Therapeutic use of coenzyme Q 10 and coenzyme Q 10 -related compounds and formulations
Villalba, J. M., Parrado‐Fernández, C., González, M. S., & Alcain, F. J. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543781003727495 · Cited by 139
Yamada, Y., Furukawa, R., Yasuzaki, Y., & Harashima, H. (2011) · Molecular Therapy · doi:10.1038/mt.2011.99 · Cited by 136
Transferrin-Conjugated Liposome Targeting of Photosensitizer AlPcS4 to Rat Bladder Carcinoma Cells
Derycke, A., Kamuhabwa, A. A. R., Gijsens, A., Roskams, T., Vos, D. E. D., Kasran, A., Huwyler, J., Missiaen, L., & de Witte, P. A. M. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh314 · Cited by 135
Sanjuán-Pla, A., Cervera, A. M., Apostolova, N., Garcia-Bou, R., Víctor, V. M., Murphy, M. P., & McCreath, K. J. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.03.088 · Cited by 134
Thermo- and light responsive micellation of azobenzene containing block copolymers
Jochum, F. D., & Théato, P. (2010) · Chemical Communications · doi:10.1039/c0cc01288b · Cited by 133
El‐Dakdouki, M. H., Zhu, D. C., El‐Boubbou, K., Kamat, M. N., Chen, J., Li, W., & Huang, X. (2012) · Biomacromolecules · doi:10.1021/bm300046h · Cited by 129
Florence, A. T., & Halbert, G. (1985) · Physics in Technology · doi:10.1088/0305-4624/16/4/303 · Cited by 126
Sneh-Edri, H., Likhtenshtein, D., & Stepensky, D. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200198c · Cited by 125
Kaaki, K., Hervé-Aubert, K., Chiper, M., Shkilnyy, A., Soucé, M., Benoit, R., Paillard, A., Dubois, P., Saboungi, M., & Chourpa, I. (2011) · Langmuir · doi:10.1021/la2037845 · Cited by 122
Aroui, S., Brahim, S., WAARD, M. M. D., & Kénani, A. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.11.073 · Cited by 122
Yamada, Y., Akita, H., Kogure, K., Kamiya, H., & Harashima, H. (2006) · Mitochondrion · doi:10.1016/j.mito.2006.12.003 · Cited by 118
Liang, B., He, M., Chan, C.-Y., Chen, Y., Li, X., Li, Y., Zheng, D., Lin, M. C. M., Kung, H., Shuai, X., et al. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.04.011 · Cited by 116
Octaarginine-modified liposomes: Enhanced cellular uptake and controlled intracellular trafficking
Khalil, I. A., Kogure, K., Futaki, S., & Harashima, H. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.12.003 · Cited by 116
Burns, R. J., Smith, R. A. J., & Murphy, M. P. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.1436 · Cited by 114
Chen, J., Wu, H., Deyan, H., & Xie, C. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.01.024 · Cited by 114
Cationic bolasomes with delocalized charge centers as mitochondria-specific DNA delivery systems
Weissig, V., & Torchilin, V. P. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00131-4 · Cited by 113
Self-citationDQAsome/DNA complexes release DNA upon contact with isolated mouse liver mitochondria
Weissig, V., D’Souza, G. G. M., & Torchilin, V. P. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00392-3 · Cited by 112
Self-citationSelective DNA Release from DQAsome/DNA Complexes at Mitochondria-Like Membranes
Weissig, V., Lizano, C., & Torchilin, V. P. (2000) · Drug Delivery · doi:10.1080/107175400266722 · Cited by 112
Self-citationOVCAR-3 cells internalize TAT-peptide modified liposomes by endocytosis
Fretz, M. M., Koning, G. A., Mastrobattista, E., Jiskoot, W., & Storm, G. (2004) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2004.06.022 · Cited by 110
Lowes, D. A., Wallace, C. A., Murphy, M. P., Webster, N. R., & Galley, H. F. (2009) · Free Radical Research · doi:10.1080/10715760902736275 · Cited by 105
Ackermann, E. J., Taylor, J. K., Narayana, R., & Bennett, C. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.11245 · Cited by 104
Pharmaceutical Perspectives of Cancer Therapeutics
Lu, Y. W., & Mahato, R. I. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0131-6 · Cited by 93
Ko, Y. T., Hartner, W. C., Kale, A. A., & Torchilin, V. P. (2008) · Gene Therapy · doi:10.1038/gt.2008.135 · Cited by 93
Self-citationKoshkaryev, A., Piroyan, A., & Torchilin, V. P. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.13.1.18871 · Cited by 92
Self-citationLi, X., Marani, M., Yu, J., Nan, B., Roth, J. A., Kagawa, S., Fang, B., Denner, L. A., & Marcelli, M. (2001) · PubMed · Cited by 91
Ultrasonic Nanotherapy of Pancreatic Cancer: Lessons from Ultrasound Imaging
Rapoport, N. Y., Kennedy, A., Shea, J., Scaife, C. L., & Nam, K.-H. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900128x · Cited by 90
Uptake and trafficking of liposomes to the endoplasmic reticulum
Pollock, S., Antrobus, R., Newton, L., Kampa, B., Rossa, J., Latham, S., Nichita, N. B., Dwek, R. A., & Zitzmann, N. (2010) · The FASEB Journal · doi:10.1096/fj.09-145755 · Cited by 90
A Multifunctional Envelope-type Nanodevice for Use in Nanomedicine: Concept and Applications
Nakamura, T., Akita, H., Yamada, Y., Hatakeyama, H., & Harashima, H. (2012) · Accounts of Chemical Research · doi:10.1021/ar200254s · Cited by 88
Biswas, S., Dodwadkar, N. S., Sawant, R. R., Koshkaryev, A., & Torchilin, V. P. (2011) · Journal of drug targeting · doi:10.3109/1061186x.2010.536983 · Cited by 86
Self-citationMT-MMPs play pivotal roles in cancer dissemination
Yana, I., & Seiki, M. (2002) · Clinical & Experimental Metastasis · doi:10.1023/a:1015527220537 · Cited by 82
Octaarginine- and pH sensitive fusogenic peptide-modified nanoparticles for liver gene delivery
Khalil, I. A., Hayashi, Y., Mizuno, R., & Harashima, H. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.012 · Cited by 82
Biswas, S., Dodwadkar, N. S., Deshpande, P. P., Parab, S., & Torchilin, V. P. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.12.021 · Cited by 81
Self-citationp53--An Acrobat in Tumorigenesis
Moll, U. M., & Schramm, L. (1998) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411980090010101 · Cited by 81
Anti‐neovascular therapy by liposomal drug targeted to membrane type‐1 matrix metalloproteinase
Kondo, M., Asai, T., Katanasaka, Y., Sadzuka, Y., Tsukada, H., Ogino, K., Taki, T., Baba, K., & Oku, N. (2003) · International Journal of Cancer · doi:10.1002/ijc.11526 · Cited by 79
Kogure, K., Akita, H., & Harashima, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.06.018 · Cited by 78
Yasuzaki, Y., Yamada, Y., & Harashima, H. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.05.070 · Cited by 78
Caveolae-An Alternative Endocytotic Pathway for Targeted Drug Delivery
Báthori, G., Cervenak, L., & Karádi, I. (2004) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v21.i2.10 · Cited by 73
Shuai, X. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s29328 · Cited by 70
Pero, S. C., Shukla, G. S., Cookson, M. M., Flemer, S., & Krag, D. N. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603732 · Cited by 69
Ri, M., Od, M., Lc, S., & Rolland, A. P. (1999) · PubMed · Cited by 64
Futaki, S., Niwa, M., Nakase, I., Tadokoro, A., Zhang, Y., Nagaoka, M., Wakako, N., & Sugiura, Y. (2004) · Bioconjugate Chemistry · doi:10.1021/bc034181g · Cited by 61
A novel IRQ ligand-modified nano-carrier targeted to a unique pathway of caveolar endocytic pathway
Mudhakir, D., Akita, H., Tan, E., & Harashima, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.10.020 · Cited by 61
Shaheen, S. M., Akita, H., Nakamura, T., Takayama, S., Futaki, S., Yamashita, A., Katoono, R., Yui, N., & Harashima, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.014 · Cited by 60
Collas, P., & Aleström, P. (1996) · Molecular Reproduction and Development · Cited by 59
Satchi‐Fainaro, R., & Duncan, R. (2005) · Advances in polymer science · doi:10.1007/11547785 · Cited by 59
Novel HPMA Copolymer-Bound Constructs for Combined Tumor and Mitochondrial Targeting
Cuchelkar, V., Kopečková, P., & Kopec̆ek, J. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800019g · Cited by 57
Functional coating of liposomes using a folate–polymer conjugate to target folate receptors
Maitani, Y., Kaneko, & †↑, W. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s32853 · Cited by 56
Bleomycin in octaarginine-modified fusogenic liposomes results in improved tumor growth inhibition
Koshkaryev, A., Piroyan, A., & Torchilin, V. P. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.06.008 · Cited by 54
Self-citationThe utilization of pathogen-like cellular trafficking by single chain block copolymer
Sahay, G., Gautam, V., Luxenhofer, R., & Kabanov, A. V. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.11.020 · Cited by 52
Kong, F., Wang, Zhou, Ge, G., & Liu (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s31915 · Cited by 49
Cited by
Design of liposomes as drug delivery system for therapeutic applications
Guimarães, D., Cavaco-Paulo, A., & Nogueira, E. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120571 · Cited by 1,196
Nanocarriers for cancer-targeted drug delivery
Kumari, P., Ghosh, B., & Biswas, S. (2016) · Journal of Drug Targeting · doi:10.3109/1061186x.2015.1051049 · Cited by 607
Self-citationA holistic approach to targeting disease with polymeric nanoparticles
Cheng, C. J., Tietjen, G. T., Saucier-Sawyer, J. K., & Saltzman, W. M. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4503 · Cited by 480
Xie, J., Bi, Y., Zhang, H., Dong, S., Teng, L., Lee, R. J., & Yang, Z. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00697 · Cited by 466
Silk fibroin nanoparticle as a novel drug delivery system
Mottaghitalab, F., Farokhi, M., Shokrgozar, M. A., Atyabi, F., & Hosseinkhani, H. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.020 · Cited by 444
Metadata
- Authors
- Biswas, S., & Torchilin, V. P.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2014-02
- Volume
- 66
- Pages
- 26-41
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2094439964
- Cited by
- 292
- References
- 213
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.